Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Venture Life Group PLC

VLG
Current price
48 GBX 0 GBX (0.00%)
Last closed 48 GBX
ISIN GB00BFPM8908
Sector Consumer Defensive
Industry Household & Personal Products
Exchange London Exchange
Capitalization 61 112 440 GBX
Yield for 12 month +54.84 %
1Y
3Y
5Y
10Y
15Y
VLG
21.11.2021 - 28.11.2021

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti. In addition, the company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ brand. Further, it provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos, as well as Glucogel for the treatment of hypoglycaemia. Additionally, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; Baby Earol, an ear spray for babies; and Sterinase for relieving blocked noses, clearing nasal passages, and preventing the risk of allergic reactions and infections. It also provides oncology support products, such as Pomi-T, used for the management of prostate-specific antigen levels in prostate cancer; Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis; and Xonrid, a hyaluronic acid based topical gel, for the prevention and treatment of Radiation Induced Dermatitis. The company was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom. Address: 12 The Courtyard, Bracknell, United Kingdom, RG12 2XB

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5 162.94 GBX

P/E ratio

48

Dividend Yield

Current Year

+5 151 747 848 GBX

Last Year

+4 407 194 537 GBX

Current Quarter

+2 801 444 554 GBX

Last Quarter

+2 350 303 294 GBX

Current Year

+1 353 423 551 GBX

Last Year

+1 770 193 064 GBX

Current Quarter

+812 895 918 GBX

Last Quarter

+540 527 709 GBX

Key Figures VLG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 8 592 956 GBX
Operating Margin TTM 10.51 %
PE Ratio 48
Return On Assets TTM 2.01 %
PEG Ratio
Return On Equity TTM 1.21 %
Wall Street Target Price 5 162.94 GBX
Revenue TTM 51 517 478 GBX
Book Value 0.6 GBX
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 11.3 %
Dividend Yield
Gross Profit TTM 12 985 090 GBX
Earnings per share 0.01 GBX
Diluted Eps TTM 0.01 GBX
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY 223.2 %
Profit Margin 1.79 %

Dividend Analytics VLG

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History VLG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 24.05.2018
Forward Annual Dividend Yield
Last Split Factor 722:721
Payout Ratio
Last Split Date 23.11.2020
Dividend Date

Stock Valuation VLG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 48
Forward PE 6.9541
Enterprise Value Revenue 1.5514
Price Sales TTM 1.1862
Enterprise Value EBITDA 8.0172
Price Book MRQ 0.7998

Financials VLG

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators VLG

For 52 weeks

27.06 GBX 51.4 GBX
50 Day MA 46.9 GBX
Shares Short Prior Month
200 Day MA 40.26 GBX
Short Ratio
Shares Short
Short Percent